NT-I7 (Efineptakin Alfa) in Combination With Pembrolizumab in Participants With Advanced Solid Tumors
NeoImmuneTech
NeoImmuneTech
Merck Sharp & Dohme LLC
Merck Sharp & Dohme LLC
University of California, San Diego
Mayo Clinic
National Cancer Institute (NCI)
Boehringer Ingelheim
CHU de Reims
Revolution Medicines, Inc.